Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 032345/0040 | |
| Pages: | 8 |
| | Recorded: | 03/04/2014 | | |
| Attorney Dkt #: | 079473.5 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/02/2017
|
Application #:
|
13502917
|
Filing Dt:
|
06/22/2012
|
|
Publication #:
|
|
Pub Dt:
|
10/04/2012
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING TRYPSINOGEN AND/OR CHYMOTRYPSINOGEN AND AN ACTIVE AGENT SELECTED FROM A SELENIUM COMPOUND, A VANILLOID COMPOUND AND A CYTOPLASMIC GLYCOLYSIS REDUCTION AGENT
|
|
|
Assignee
|
|
|
|
|
| 576 SWAN STREET |
| RICHMOND, AUSTRALIA 3121 |
|
|
Correspondence name and address
|
| |
BEVERLY A. LYMAN, PH.D.
|
| |
3560 LENOX ROAD
|
| |
SUITE 1600
|
| |
ATLANTA, GA 30326
|
Search Results as of:
09/23/2024 07:54 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
